Laurus Labs Q2: Shares Fall Over 3% Despite Surge In Net Profit
Laurus Labs Ltd. shares declined over 3% on Friday, a day after the company reported strong second-quarter earnings. The decline comes despite the pharmaceutical firm posting a robust performance for the July–September period, with consolidated revenue rising 35.1% year-on-year to Rs 1,653.47 crore and net profit surging 883% to Rs 194.97 crore.
Laurus Labs is a research-driven pharmaceutical manufacturing organisation established in 2005. The company is involved in developing and manufacturing Active Pharmaceutical Ingredients (APIs) and Intermediates. The company says its position was strengthened by their backward-integration capability while remaining highly regulatory compliant across all operations.
Laurus Labs Q2 Highlights (Cons, YoY)
Revenue up 35.1% to Rs 1,653.47 crore versus Rs 1,223.70 crore.
Net Profit up 883% to Rs 194.97 crore versus Rs 19.84 crore.
Ebitda up 126% to Rs 403.26 crore versus Rs 178.33 crore.
Margin at 24.4% versus 14.6%.

The scrip fell as much as 3.43% to Rs 902.35 apiece. It pared losses to trade 0.88% lower at Rs 926.20 apiece, as of 10:30 a.m. This compares to a 0.27% decline in the NSE Nifty 50 Index.
It has risen 107.98% in the last 12 months. Total traded volume so far in the day stood at 2.5 times its 30-day average. The relative strength index was at 71.
Out of 17 analysts tracking the company, eight maintain a 'buy' rating, three recommend a 'hold,' and six suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 2.4%
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.